Release Date: 04/02/21 09:07 Summary: Completes $1.1M delivery GCS solution part of $2.3M contract Price Sensitive: Yes Download Document 400.1KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%